United Therapeutics Corporation
UTHR
$307.24
$1.850.61%
| Weiss Ratings | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Price History | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.14% | |||
| 30-Day Total Return | -12.51% | |||
| 60-Day Total Return | -17.59% | |||
| 90-Day Total Return | -17.85% | |||
| Year to Date Total Return | -14.71% | |||
| 1-Year Total Return | 30.31% | |||
| 2-Year Total Return | 41.26% | |||
| 3-Year Total Return | 71.82% | |||
| 5-Year Total Return | 286.81% | |||
| 52-Week High % Change | -26.47% | |||
| 52-Week Low % Change | 38.69% | |||
| Price | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $417.82 | |||
| 52-Week Low Price | $221.53 | |||
| 52-Week Low Price (Date) | Apr 01, 2024 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| Valuation | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 13.80B | |||
| Enterprise Value | 9.40B | |||
| Price/Earnings (TTM) | 12.49 | |||
| Earnings Per Share (TTM) | 24.59 | |||
| Earnings Per Share Growth | 24.01% | |||
| Price/Earnings To Growth | 0.52 | |||
| Price/Sales (TTM) | 5.20 | |||
| Price/Book (Q) | 2.14 | |||
| Enterprise Value/Revenue (TTM) | 3.27 | |||
| Price | $307.24 | |||
| Enterprise Value/EBITDA (TTM) | 6.19 | |||
| Enterprise Value/EBIT | 6.50 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.70M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 301 608 9292 | |||
| Address | 1000 Spring Street Silver Spring, MD 20910 | |||
| Website | www.unither.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 50.26% | |||
| Profit Margin | 41.53% | |||
| Management Effectiveness | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 12.44% | |||
| Return on Equity | 19.23% | |||
| Income Statement | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.88B | |||
| Total Revenue (TTM) | 2.88B | |||
| Revenue Per Share | $59.08 | |||
| Gross Profit (TTM) | 2.57B | |||
| EBITDA (TTM) | 1.52B | |||
| EBIT (TTM) | 1.45B | |||
| Net Income (TTM) | 1.20B | |||
| Net Income Avl. to Common (TTM) | 1.20B | |||
| Total Revenue Growth (Q YOY) | 19.72% | |||
| Earnings Growth (Q YOY) | 38.78% | |||
| EPS Diluted (TTM) | 24.59 | |||
| EPS Diluted Growth (Q YOY) | 42.09% | |||
| Balance Sheet | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.27B | |||
| Cash Per Share (Q) | $67.08 | |||
| Total Current Assets (Q) | 3.87B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.44B | |||
| Current Ratio (Q) | 5.248 | |||
| Book Value Per Share (Q) | $143.74 | |||
| Total Assets (Q) | 7.36B | |||
| Total Current Liabilities (Q) | 738.10M | |||
| Total Debt (Q) | 338.60M | |||
| Total Liabilities (Q) | 920.00M | |||
| Total Common Equity (Q) | 6.44B | |||
| Cash Flow | UTHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 417.20M | |||
| Cash from Financing (TTM) | -1.25B | |||
| Net Change in Cash (TTM) | 489.50M | |||
| Levered Free Cash Flow (TTM) | 829.43M | |||
| Cash from Operations (TTM) | 1.33B | |||
